Arcutis Biotherapeutics, Inc. Financial Ratios — ARQT Stock

Profitability	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-70.12	-53.12	-66.96	-58.42	-72.65	-66.31
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	79.54	91.63
EBITDA Margin (%)	- -	- -	- -	- -	- -	-8,157.7	-401.94
Operating Margin (%)	- -	- -	- -	- -	- -	-8,183.04	-404.49
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	-8,449.76	-434.57
Profit Margin (%)	- -	- -	- -	- -	- -	-8,449.76	-439.79
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	-8,449.76	-439.79
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	0.39	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -

Credit	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Debt	- -	- -	- -	5	78	203	206
ST Debt	- -	- -	- -	- -	- -	1	1
LT Debt	- -	- -	- -	5	77	202	205
Total Debt/EBITDA	- -	- -	-0.01	-0.04	-0.38	-0.67	-0.86
Net Debt/EBITDA	0.83	2	1.47	0.48	0.12	-0.48	-0.47
Total Debt/EBIT	- -	- -	-0.01	-0.04	-0.38	-0.67	-0.85
Net Debt/EBIT	0.83	2	1.47	0.48	0.12	-0.48	-0.47
EBITDA to Interest Expense	- -	- -	- -	- -	- -	-19.21	-8.06
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	-20.7	-8.08
EBIT to Interest Expense	- -	- -	- -	- -	- -	-19.27	-8.11
Interest Expense	- -	- -	- -	- -	- -	16	30
Common Equity/Total Assets	-131.47	-47.51	-61.93	-67.71	-100.04	-160.2	-287.64
Long-Term Debt/Equity (%)	- -	- -	- -	1.83	25.91	96.33	231.41
Long-Term Debt/Capital (%)	- -	- -	-0.2	-2.52	-23.32	-39.03	-26.44
Long-Term Debt/Total Assets (%)	- -	- -	0.12	1.66	18.9	44.94	60.11
Total Debt/Equity (%)	- -	- -	-0.47	1.83	26.05	96.64	232.24
Total Debt/Capital (%)	- -	- -	-0.47	-2.52	-23.45	-39.16	-26.54
Total Debt/Total Assets (%)	- -	- -	0.29	1.66	19	45.08	60.32
Net Debt to Equity	68.46	164.23	97.4	-24.05	-8.1	68.77	127.9
Net Debt/Capital (%)	40.5	61.87	48.98	24.83	5.64	-25.25	-13.12
EBITDA	-4	-20	-43	-137	-206	-301	-240
EBITDA-CapEx	-4	-20	-43	-137	-207	-324	-240
Operating Income (Loss)	-4	-20	-43	-137	-207	-302	-241

Liquidity	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Cash Ratio	4.94	19.06	19.34	12.58	11.61	10.83	5.83
Current Ratio	5.52	19.12	20.33	12.96	12.09	11.57	7.08
Quick Ratio	4.94	19.06	19.36	12.61	11.61	11.06	6.38
CFO/Avg Current Liab	- -	-8.37	-10.83	-8.12	-6.24	-7.25	-5.85
Common Equity/Total Assets	-131.47	-47.51	-61.93	-67.71	-100.04	-160.2	-287.64
Long-Term Debt/Equity (%)	- -	- -	- -	1.83	25.91	96.33	231.41
Long-Term Debt/Capital (%)	- -	- -	-0.2	-2.52	-23.32	-39.03	-26.44
Long-Term Debt/Total Assets (%)	- -	- -	0.12	1.66	18.9	44.94	60.11
Total Debt/Equity (%)	- -	- -	-0.47	1.83	26.05	96.64	232.24
Total Debt/Capital (%)	- -	- -	-0.47	-2.52	-23.45	-39.16	-26.54
Total Debt/Total Assets (%)	- -	- -	0.29	1.66	19	45.08	60.32
CFO/Total Liabilities	-42.84	-18.76	-24.9	-408.83	-158.07	-107.52	-97.77
CFO/CapEx	- -	- -	-145.21	-352.13	-175.5	-11.07	-577.24
Altman's Z-Score	-4.41	-0.8	-1.06	20.4	3.58	-1.4	-4.75

Working Capital	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	0.87	3.48
Days Sales Outstanding	- -	- -	- -	- -	- -	418.77	104.91
Inventory Turnover	- -	- -	- -	- -	- -	0.2	0.48
Days Inventory Outstanding	- -	- -	- -	- -	- -	1,818.71	755.62
Accounts Payable Turnover	- -	- -	- -	- -	- -	1.02	1.02
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	357.14	358.2
Cash Conversion Cycle	- -	- -	- -	- -	- -	1,880.33	502.32
Inventory to Cash Days	- -	- -	- -	- -	- -	-1,399.94	-650.7
Inventories	- -	- -	- -	- -	- -	8	13
Raw Materials	- -	- -	- -	- -	- -	6	10
Work In Process	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	1	3
Other Inventory	- -	- -	- -	- -	- -	- -	- -

Enterprise Value	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Market Capitalization	- -	- -	- -	1,003	1,025	814	224
- Cash & Cash Equivalents	3	39	63	65	96	54	88
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	5	78	203	206
Enterprise Value	-3	-51	-101	724	715	607	158
Total Capital	-5	-24	-66	-197	-331	-517	-776
Total Debt/Capital (%)	- -	- -	-0.47	-2.52	-23.45	-39.16	-26.54
Total Debt / EV	- -	- -	- -	0.01	0.11	0.33	1.3
EV/Sales	- -	- -	- -	- -	- -	164.79	2.65
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	1,003	1,025	814	224
Diluted Enterprise Value	-3	-39	-63	943	1,006	963	341
EV per Share	- -	- -	- -	20.29	14.48	11.04	2.28
TTM Sales	- -	- -	- -	- -	- -	4	60
TTM EBITDA	-4	-20	-43	-137	-206	-301	-240
TTM Operating Income	-4	-20	-43	-137	-207	-302	-241
TTM Cash Flow to Firm	-4	-14	-43	-113	-175	-242	-217
TTM Free Cash Flow to Firm	-4	-14	-43	-113	-174	-219	-217

Multiples	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Price/Earnings	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-7.03	-6.09	-3.43	-2.42
Price/Earnings High	- -	- -	- -	-10.75	-9.22	-4.84	-4.64
Price/Earnings Low	- -	- -	- -	-4.5	-3.39	-2.36	-0.47
Price/Book Value	- -	- -	- -	-4.97	-2.51	-1.13	-0.23
Price/Book Value Average	- -	- -	- -	-4.72	-3.08	-1.48	-0.65
Price/Book Value High	- -	- -	- -	-7.22	-4.66	-2.09	-1.24
Price/Book Value Low	- -	- -	- -	-3.02	-1.71	-1.02	-0.12
Price/Tangible Book Value	- -	- -	- -	3.71	3.44	4.02	2.72
Price/Tangible Book Value Average	- -	- -	- -	3.52	4.22	5.28	7.73
Price/Tangible Book Value High	- -	- -	- -	5.39	6.39	7.45	14.81
Price/Tangible Book Value Low	- -	- -	- -	2.25	2.35	3.64	1.48
Price/Sales	- -	- -	- -	- -	- -	220.97	3.76
Price/Sales Average	- -	- -	- -	- -	- -	289.76	10.66
Price/Sales High	- -	- -	- -	- -	- -	409.08	20.43
Price/Sales Low	- -	- -	- -	- -	- -	199.62	2.05
Price/Cash Flow	- -	- -	- -	-8.88	-5.87	-3.16	-0.91
Price/Cash Flow Average	- -	- -	- -	-8.43	-7.2	-4.14	-2.57
Price/Cash Flow High	- -	- -	- -	-12.9	-10.89	-5.85	-4.93
Price/Cash Flow Low	- -	- -	- -	-5.4	-4.01	-2.86	-0.49
Price/Free Cash Flow	- -	- -	- -	-8.9	-5.9	-3.47	-0.91
Price/Free Cash Flow Average	- -	- -	- -	-8.46	-7.24	-4.56	-2.58
Price/Free Cash Flow High	- -	- -	- -	-12.94	-10.95	-6.43	-4.94
Price/Free Cash Flow Low	- -	- -	- -	-5.41	-4.03	-3.14	-0.49
EV/Sales	- -	- -	- -	- -	- -	164.79	2.65
EV/Sales Average	- -	- -	- -	- -	- -	330.15	12.63
EV/Sales High	- -	- -	- -	- -	- -	449.48	22.4
EV/Sales Low	- -	- -	- -	- -	- -	240.01	4.02
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	0.83	2	1.46	-6.54	-6.01	-4.05	-3.14
EV/EBITDA High	0.83	2	1.46	-10.24	-9.14	-5.51	-5.57
EV/EBITDA Low	0.83	2	1.46	-4.03	-3.3	-2.94	-1
EV/EBIT	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Average	0.83	2	1.46	-6.54	-6	-4.03	-3.12
EV/EBIT High	0.83	2	1.46	-10.23	-9.12	-5.49	-5.54
EV/EBIT Low	0.83	2	1.46	-4.02	-3.3	-2.93	-0.99
Last Price	- -	- -	- -	28.13	20.74	14.8	3.23
High Price	- -	- -	- -	40.88	38.49	27.4	17.57
Low Price	- -	- -	- -	17.1	14.16	13.37	1.76
Enterprise Value	-3	-51	-101	724	715	607	158
Enterprise Value Average	-3	-39	-63	893	1,238	1,217	753
Enterprise Value High	-3	-39	-63	1,398	1,883	1,657	1,335
Enterprise Value Low	-3	-39	-63	550	681	885	239

Per Share Data Items	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Shares Outstanding	35	35	35	43	50	61	97
Diluted Weighted Avg Shares	18	18	35	36	49	55	69
Basic Weighted Avg Shares	18	18	35	36	49	55	69
Revenue per Share	- -	- -	- -	- -	- -	0.07	0.86
EBITDA per Share	-0.23	-1.09	-1.23	-3.83	-4.17	-5.46	-3.46
Operating Income per Share	-0.23	-1.09	-1.23	-3.83	-4.18	-5.48	-3.48
Basic EPS, GAAP	-0.28	-1.07	-1.2	-3.8	-4.18	-5.66	-3.78
Basic EPS from Cont Ops	-0.28	-1.07	-1.2	-3.8	-4.18	-5.66	-3.78
Diluted EPS, GAAP	-0.28	-1.07	-1.2	-3.8	-4.18	-5.66	-3.78
Diluted EPS from Cont Ops	-0.28	-1.07	-1.2	-3.8	-4.18	-5.66	-3.78
Dividend per Share	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.21	-0.78	-1.22	-3.17	-3.53	-4.68	-3.56
Free Cash Flow per Basic Share	-0.21	-0.78	-1.23	-3.18	-3.55	-5.11	-3.57
Cash & Equivalents per Share	0.19	2.82	2.89	7.97	7.83	7.44	3.92
Book Value per Share	-0.28	-1.35	-1.89	-5.66	-8.26	-13.08	-14.17
Tangible Book Value per Share	-0.28	-1.33	-1.85	7.59	6.03	3.68	1.19

Arcutis Biotherapeutics, Inc.

Profitability

Credit

Liquidity

Working Capital

Enterprise Value

Multiples

Per Share Data Items